カテゴリー： QYResearch, 世界

世界のPET放射性医薬品市場

◆英語タイトル：Global PET Radiopharmaceuticals Market Professional Survey Report 2019
◆商品コード：DATA909X12848
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、PET放射性医薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、F-18、Ru-82、その他に、用途別には、腫瘍学、心臓病学、神経学、その他にセグメント区分し、PET放射性医薬品の世界市場を分析しました。

・エグゼクティブ・サマリー
・PET放射性医薬品の世界市場概要
・PET放射性医薬品の製造コスト構成分析
・PET放射性医薬品の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・PET放射性医薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・PET放射性医薬品のセグメント分析（種類別）
（F-18、Ru-82、その他）
・PET放射性医薬品のセグメント分析（用途別）
（腫瘍学、心臓病学、神経学、その他）
・PET放射性医薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Cardinal Health Inc. (U.S.)、Mallinckrodt plc (Ireland)、GE Healthcare (U.K.)、Lantheus Medical Imaging, Inc. (U.S.)、Bayer AG (Germany)、Bracco Imaging S.p.A (Italy)、Eczacibasi-Monrol Nuclear Products (Turkey)、Nordion, Inc. (Canada)、Advanced Accelerator Applications S.A. (France)、IBA Molecular Imaging (Belgium)、）
・PET放射性医薬品の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global PET Radiopharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on PET Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall PET Radiopharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of PET Radiopharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their PET Radiopharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
F-18
Ru-82
Others

Segment by Application
Oncology
Cardiology
Neurology
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of PET Radiopharmaceuticals
1.1 Definition of PET Radiopharmaceuticals
1.2 PET Radiopharmaceuticals Segment by Type
1.2.1 Global PET Radiopharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 PET Radiopharmaceuticals Segment by Applications
1.3.1 Global PET Radiopharmaceuticals Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Global PET Radiopharmaceuticals Overall Market
1.4.1 Global PET Radiopharmaceuticals Revenue (2014-2025)
1.4.2 Global PET Radiopharmaceuticals Production (2014-2025)
1.4.3 North America PET Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.4 Europe PET Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.5 China PET Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.6 Japan PET Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.7 Southeast Asia PET Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.8 India PET Radiopharmaceuticals Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
2.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
2.4 Industry Chain Structure of PET Radiopharmaceuticals

3 Development and Manufacturing Plants Analysis of PET Radiopharmaceuticals
3.1 Capacity and Commercial Production Date
3.2 Global PET Radiopharmaceuticals Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of PET Radiopharmaceuticals
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 PET Radiopharmaceuticals Production and Capacity Analysis
4.2 PET Radiopharmaceuticals Revenue Analysis
4.3 PET Radiopharmaceuticals Price Analysis
4.4 Market Concentration Degree

5 PET Radiopharmaceuticals Regional Market Analysis
5.1 PET Radiopharmaceuticals Production by Regions
5.1.1 Global PET Radiopharmaceuticals Production by Regions
5.1.2 Global PET Radiopharmaceuticals Revenue by Regions
5.2 PET Radiopharmaceuticals Consumption by Regions
5.3 North America PET Radiopharmaceuticals Market Analysis
5.3.1 North America PET Radiopharmaceuticals Production
5.3.2 North America PET Radiopharmaceuticals Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America PET Radiopharmaceuticals Import and Export
5.4 Europe PET Radiopharmaceuticals Market Analysis
5.4.1 Europe PET Radiopharmaceuticals Production
5.4.2 Europe PET Radiopharmaceuticals Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe PET Radiopharmaceuticals Import and Export
5.5 China PET Radiopharmaceuticals Market Analysis
5.5.1 China PET Radiopharmaceuticals Production
5.5.2 China PET Radiopharmaceuticals Revenue
5.5.3 Key Manufacturers in China
5.5.4 China PET Radiopharmaceuticals Import and Export
5.6 Japan PET Radiopharmaceuticals Market Analysis
5.6.1 Japan PET Radiopharmaceuticals Production
5.6.2 Japan PET Radiopharmaceuticals Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan PET Radiopharmaceuticals Import and Export
5.7 Southeast Asia PET Radiopharmaceuticals Market Analysis
5.7.1 Southeast Asia PET Radiopharmaceuticals Production
5.7.2 Southeast Asia PET Radiopharmaceuticals Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia PET Radiopharmaceuticals Import and Export
5.8 India PET Radiopharmaceuticals Market Analysis
5.8.1 India PET Radiopharmaceuticals Production
5.8.2 India PET Radiopharmaceuticals Revenue
5.8.3 Key Manufacturers in India
5.8.4 India PET Radiopharmaceuticals Import and Export

6 PET Radiopharmaceuticals Segment Market Analysis (by Type)
6.1 Global PET Radiopharmaceuticals Production by Type
6.2 Global PET Radiopharmaceuticals Revenue by Type
6.3 PET Radiopharmaceuticals Price by Type

7 PET Radiopharmaceuticals Segment Market Analysis (by Application)
7.1 Global PET Radiopharmaceuticals Consumption by Application
7.2 Global PET Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

8 PET Radiopharmaceuticals Major Manufacturers Analysis
8.1 Cardinal Health Inc. (U.S.)
8.1.1 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
8.1.2 Cardinal Health Inc. (U.S.) Product Introduction, Application and Specification
8.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Mallinckrodt plc (Ireland)
8.2.1 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Sites and Area Served
8.2.2 Mallinckrodt plc (Ireland) Product Introduction, Application and Specification
8.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GE Healthcare (U.K.)
8.3.1 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Sites and Area Served
8.3.2 GE Healthcare (U.K.) Product Introduction, Application and Specification
8.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Lantheus Medical Imaging, Inc. (U.S.)
8.4.1 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
8.4.2 Lantheus Medical Imaging, Inc. (U.S.) Product Introduction, Application and Specification
8.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer AG (Germany)
8.5.1 Bayer AG (Germany) PET Radiopharmaceuticals Production Sites and Area Served
8.5.2 Bayer AG (Germany) Product Introduction, Application and Specification
8.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bracco Imaging S.p.A (Italy)
8.6.1 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Sites and Area Served
8.6.2 Bracco Imaging S.p.A (Italy) Product Introduction, Application and Specification
8.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eczacibasi-Monrol Nuclear Products (Turkey)
8.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Sites and Area Served
8.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Product Introduction, Application and Specification
8.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Nordion, Inc. (Canada)
8.8.1 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Sites and Area Served
8.8.2 Nordion, Inc. (Canada) Product Introduction, Application and Specification
8.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Advanced Accelerator Applications S.A. (France)
8.9.1 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Sites and Area Served
8.9.2 Advanced Accelerator Applications S.A. (France) Product Introduction, Application and Specification
8.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 IBA Molecular Imaging (Belgium)
8.10.1 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Sites and Area Served
8.10.2 IBA Molecular Imaging (Belgium) Product Introduction, Application and Specification
8.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of PET Radiopharmaceuticals Market
9.1 Global PET Radiopharmaceuticals Market Trend Analysis
9.1.1 Global PET Radiopharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
9.2 PET Radiopharmaceuticals Regional Market Trend
9.2.1 North America PET Radiopharmaceuticals Forecast 2019-2025
9.2.2 Europe PET Radiopharmaceuticals Forecast 2019-2025
9.2.3 China PET Radiopharmaceuticals Forecast 2019-2025
9.2.4 Japan PET Radiopharmaceuticals Forecast 2019-2025
9.2.5 Southeast Asia PET Radiopharmaceuticals Forecast 2019-2025
9.2.6 India PET Radiopharmaceuticals Forecast 2019-2025
9.3 PET Radiopharmaceuticals Market Trend (Product Type)
9.4 PET Radiopharmaceuticals Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 PET Radiopharmaceuticals Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of PET Radiopharmaceuticals
Table Global PET Radiopharmaceuticals Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global PET Radiopharmaceuticals Production Market Share by Types in 2018
Figure F-18 Product Picture
Figure Ru-82 Product Picture
Figure Others Product Picture
Table Global PET Radiopharmaceuticals Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global PET Radiopharmaceuticals Consumption Market Share by Applications in 2018
Figure Oncology
Figure Cardiology
Figure Neurology
Figure Others
Figure Global PET Radiopharmaceuticals Revenue (Million USD) (2014-2025)
Figure Global PET Radiopharmaceuticals Production (K Pcs) (2014-2025)
Figure North America PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Europe PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure China PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Japan PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Southeast Asia PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure India PET Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Table PET Radiopharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2018
Figure Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure Industry Chain Structure of PET Radiopharmaceuticals
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global PET Radiopharmaceuticals Manufacturing Plants Distribution
Table PET Radiopharmaceuticals Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table PET Radiopharmaceuticals Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table PET Radiopharmaceuticals Production (K Pcs) of Major Manufacturers (2014-2019)
Table PET Radiopharmaceuticals Production Market Share of Major Manufacturers (2014-2019)
Figure PET Radiopharmaceuticals Production Share by Manufacturers in 2018
Table PET Radiopharmaceuticals Revenue (Million US$) of Major Manufacturers (2014-2019)
Table PET Radiopharmaceuticals Revenue Market Share of Major Manufacturers (2014-2019)
Figure PET Radiopharmaceuticals Revenue Share by Manufacturers in 2018
Table PET Radiopharmaceuticals Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global PET Radiopharmaceuticals Production by Regions 2014-2019 (K Pcs)
Table Global PET Radiopharmaceuticals Production Market Share by Regions 2014-2019
Figure Global PET Radiopharmaceuticals Production Market Share by Regions in 2018
Table Global PET Radiopharmaceuticals Revenue by Regions 2014-2019 (Million USD)
Table Global PET Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
Figure Global PET Radiopharmaceuticals Revenue Market Share by Regions in 2018
Table Global PET Radiopharmaceuticals Consumption by Regions 2014-2019 (K Pcs)
Table Global PET Radiopharmaceuticals Consumption Market Share by Regions 2014-2019
Figure North America PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure North America PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table North America PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure Europe PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure Europe PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Europe PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure China PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure China PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table China PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure Japan PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure Japan PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Japan PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure India PET Radiopharmaceuticals Production Growth Rate 2014-2019 (K Pcs)
Figure India PET Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table India PET Radiopharmaceuticals Production, Consumption Import and Export (K Pcs)
Figure Global Consumption PET Radiopharmaceuticals Market Share by Application (2014-2019)
Figure Global Value (Consumption) PET Radiopharmaceuticals Market Share by Application (2014-2019)
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Main Business and Markets Served
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Sites and Area Served
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Main Business and Markets Served
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Production Sites and Area Served
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure GE Healthcare (U.K.) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Main Business and Markets Served
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Main Business and Markets Served
Table Bayer AG (Germany) PET Radiopharmaceuticals Production Sites and Area Served
Table Bayer AG (Germany) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Bayer AG (Germany) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG (Germany) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Bayer AG (Germany) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Bayer AG (Germany) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Bayer AG (Germany) PET Radiopharmaceuticals Main Business and Markets Served
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Sites and Area Served
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Main Business and Markets Served
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Sites and Area Served
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Main Business and Markets Served
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Sites and Area Served
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Nordion, Inc. (Canada) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Main Business and Markets Served
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Sites and Area Served
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Main Business and Markets Served
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Sites and Area Served
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Introduction, Application and Specification
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Growth Rate (2014-2019)
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Market Share (2014-2019)
Figure IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Revenue Market Share (2014-2019)
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Main Business and Markets Served
Figure Global PET Radiopharmaceuticals Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global PET Radiopharmaceuticals Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global PET Radiopharmaceuticals Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India PET Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India PET Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of PET Radiopharmaceuticals by Type (2019-2025)
Table Global Consumption (K Pcs) of PET Radiopharmaceuticals by Application (2019-2025)
Table PET Radiopharmaceuticals Distributors List
Table PET Radiopharmaceuticals Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Cardinal Health Inc. (U.S.)、Mallinckrodt plc (Ireland)、GE Healthcare (U.K.)、Lantheus Medical Imaging, Inc. (U.S.)、Bayer AG (Germany)、Bracco Imaging S.p.A (Italy)、Eczacibasi-Monrol Nuclear Products (Turkey)、Nordion, Inc. (Canada)、Advanced Accelerator Applications S.A. (France)、IBA Molecular Imaging (Belgium)、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のPET放射性医薬品市場(Global PET Radiopharmaceuticals Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp